The Morning After Pill ella® is NOT an Abortifacient
And why you should care
And why you should care
Key PointsPatients with cancer are at high risk of clinically relevant bleeding, regardless of anticoagulation use.The occurrence of clinically relevant bl
Key Points. Axi-cel and liso-cel had similar outcomes, though when accounting for differences in risk factors, axi-cel was associated with superior PFS.We
Key Points. CD70 targeted CAR-T cells secreting a CD33 T-cell engaging antibody molecule eradicate CD33 or CD70 deficient AML
This region represents members in NYACP Districts of Manhattan and the Bronx.
Background and Objectives We assessed the accuracy of preoperative gallium-68 DOTA-Tyr3-octreotate (DOTATATE) positron emission tomography (PET) imaging in estimating multifocality and nodal metasta…
Speaker: Elie Azoulay Designation: Professor in intensive care medicine Editor in Chief of Intensive Care Medicine 2012-2018 ESICM President 2022-2024 Affiliation: University Paris Cité, Saint-Louis…
PURPOSEPD-1 inhibition is effective in patients with mismatch repair deficient (dMMR) solid tumors in a tumor-agnostic fashion. However, dMMR testing by immunohistochemistry (IHC) is not…
Although this study did not meet the primary endpoint, activity and safety profiles of primary lung tumour SBRT followed by concurrent mediastinal chemoradiotherapy were favourable…
A team of 15 determined individuals, including multiple myeloma cancer survivors, care partners, and world-renowned physicians, embark on the Iceland Cycling…
Dr. Adam Rodman joins CNN’s Erica Hill to discuss the results of a study he conducted on AI and the ability to diagnose illness.